Kairos Pharma, Ltd.
AED6.317
AED
Last updated on --.
24h volume42.02K
24h highest6.5379 AED
24h lowest6.3176 AED
24h Price movement-2.82%
KAPA recent prices
24 Hours
-2.82%-AED0.18365
30 days
+1.96%+AED0.12121
60 days
-20.22%-AED1.602
90 days
-31.17%-AED2.862
Key data
Previous close6.5012 AED
Market cap21.51M AED
Volume42.02K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-6.2808 AED
Net income (FY)-21.32M AED
Revenue (FY)0.00 AED
Last report dateAug 12, 2026
About Kairos Pharma, Ltd.
HeadquartersLOS ANGELES
Employees (FY)1.00
Revenue per employee (FY)0.00 AED
Net income per employee (FY)-21.32M AED
Listed onXASE
KAPA conversion tables
 |  |
|---|---|
| 0.5 KAPA | 3.158 AED |
| 1 KAPA | 6.317 AED |
| 5 KAPA | 31.58 AED |
| 10 KAPA | 63.17 AED |
| |
|---|---|
| 0.5 AED | 0.079144 KAPA |
| 1 AED | 0.15829 KAPA |
| 5 AED | 0.79144 KAPA |
| 10 AED | 1.582 KAPA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
KAPA is trading at AED6.317, -2.82% over the last 24 hours. Track live moves on the price chart at the top of this page.
The KAPA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. KAPA is currently trading at AED6.317, -2.82% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on KAPA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. KAPA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from KAPA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against KAPA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Kairos Pharma, Ltd.'s market cap is currently 21.51M AED. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume42.02K
24h highest6.5379 AED
24h lowest6.3176 AED
24h Price movement-2.82%
Start trade with KAPA Perpetual
Sign up to trade